Karen Benwell

1.2k total citations
16 papers, 909 citations indexed

About

Karen Benwell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Karen Benwell has authored 16 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Karen Benwell's work include Receptor Mechanisms and Signaling (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Down syndrome and intellectual disability research (3 papers). Karen Benwell is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Down syndrome and intellectual disability research (3 papers). Karen Benwell collaborates with scholars based in United Kingdom, France and Ghana. Karen Benwell's co-authors include Dean F. Revell, Richard H. Porter, G.A. Kennett, Helen Lamb, Anil Kumar Misra, David R. Adams, C Malcolm, Malcolm J. Sheardown, Mike Bickerdike and Nicola H. Allen and has published in prestigious journals such as Neurology, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Karen Benwell

16 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Benwell United Kingdom	13	493	401	180	120	104	16	909
Salvador Sierra United States	17	505 1.0×	277 0.7×	221 1.2×	100 0.8×	109 1.0×	27	935
Philip A. Iredale United States	18	511 1.0×	464 1.2×	229 1.3×	84 0.7×	95 0.9×	30	1.1k
B M Baron United States	15	767 1.6×	575 1.4×	67 0.4×	162 1.4×	71 0.7×	21	1.1k
Ludo Kennis Belgium	7	555 1.1×	537 1.3×	102 0.6×	127 1.1×	169 1.6×	12	1.1k
Penny G. Threlkeld United States	18	752 1.5×	428 1.1×	239 1.3×	102 0.8×	105 1.0×	23	1.2k
Raymond P. Ward United States	7	715 1.5×	491 1.2×	100 0.6×	115 1.0×	57 0.5×	7	954
David G. Trist Italy	22	624 1.3×	601 1.5×	149 0.8×	121 1.0×	181 1.7×	62	1.5k
Édith Doucet France	14	651 1.3×	483 1.2×	120 0.7×	143 1.2×	64 0.6×	16	976
Dinah Weissmann France	21	640 1.3×	474 1.2×	88 0.5×	37 0.3×	139 1.3×	53	1.1k
Virginia L. Lucaites United States	19	577 1.2×	491 1.2×	77 0.4×	217 1.8×	117 1.1×	24	997

Countries citing papers authored by Karen Benwell

Since Specialization

Citations

This map shows the geographic impact of Karen Benwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Benwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Benwell more than expected).

Fields of papers citing papers by Karen Benwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Benwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Benwell. The network helps show where Karen Benwell may publish in the future.

Co-authorship network of co-authors of Karen Benwell

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Benwell. A scholar is included among the top collaborators of Karen Benwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Benwell. Karen Benwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Massey, Andrew J., Karen Benwell, Mike F. Burbridge, András Kotschy, & Lee Walmsley. (2021). Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma. Journal of Cellular and Molecular Medicine. 25(22). 10650–10662. 14 indexed citations

Walmsley, Lee, James B. Murray, P. Dokurno, et al.. (2021). Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B. Journal of Medicinal Chemistry. 64(13). 8971–8991. 31 indexed citations

Wéber, Csaba, Melinda Sipos, Attila Paczal, et al.. (2021). Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors. Journal of Medicinal Chemistry. 64(10). 6745–6764. 29 indexed citations

Foloppe, Nicolas, Karen Benwell, Teresa Brooks, et al.. (2009). Discovery and functional evaluation of diverse novel human CB1 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 19(15). 4183–4190. 20 indexed citations

Kennett, G.A., Karen Benwell, Dean F. Revell, et al.. (2006). The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake. Pharmacology Biochemistry and Behavior. 84(2). 353–359. 73 indexed citations

Adams, David R., Jonathan Bentley, Karen Benwell, et al.. (2005). Pyrrolo(iso)quinoline derivatives as 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(3). 677–680. 20 indexed citations

Dourish, Colin T., Adams, Karen Benwell, et al.. (2004). Discovery and development of selective 5-HT2C receptor agonists for obesity. Fundamental and Clinical Pharmacology. 18. 127–127. 2 indexed citations

Misra, Anil Kumar, Kathleen Quirk, Karen Benwell, et al.. (2004). Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 370(2). 114–23. 193 indexed citations

Weiss, Scott Μ., Karen Benwell, Ian A. Cliffe, et al.. (2003). Discovery of nonxanthine adenosine A_2Areceptor antagonists for the treatment of Parkinson’s disease. Neurology. 61(11_suppl_6). S101–6. 64 indexed citations

10.

Weiss, Scott Μ., Karen Benwell, Ian A. Cliffe, et al.. (2003). Discovery of nonxanthine adenosine A 2A receptor antagonists for the treatment of Parkinson's disease. 61. 9 indexed citations

11.

Vickers, S P, Karen Benwell, Richard H. Porter, et al.. (2000). Comparative effects of continuous infusion of mCPP, Ro 60‐0175 and d‐fenfluramine on food intake, water intake, body weight and locomotor activity in rats. British Journal of Pharmacology. 130(6). 1305–1314. 66 indexed citations

12.

Bebbington, David, Suneel Gaur, Alan M. Palmer, et al.. (2000). 3,5-Disubstituted-4-hydroxyphenyls Linked to 3-Hydroxy-2-methyl- 4(1H)-pyridinone: Potent Inhibitors of Lipid Peroxidation and Cell Toxicity. Journal of Medicinal Chemistry. 43(15). 2779–2782. 33 indexed citations

13.

Benwell, Karen, et al.. (2000). Characterization of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells. Free Radical Biology and Medicine. 28(1). 102–107. 20 indexed citations

14.

Childs, Robert A., Christine Galustian, Alexander Lawson, et al.. (1999). Recombinant Soluble Human CD69 Dimer Produced in Escherichia coli: Reevaluation of Saccharide Binding. Biochemical and Biophysical Research Communications. 266(1). 19–23. 13 indexed citations

15.

Porter, Richard H., Karen Benwell, Helen Lamb, et al.. (1999). Functional characterization of agonists at recombinant human 5‐HT_2A, 5‐HT_2B and 5‐HT_2C receptors in CHO‐K1 cells. British Journal of Pharmacology. 128(1). 13–20. 313 indexed citations

16.

Cockett, Mark I., et al.. (1997). Simultaneous Expression of Multi-Subunit Proteins in Mammalian Cells Using a Convenient Set of Mammalian Cell Expression Vectors. BioTechniques. 23(3). 402–407. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact